Anti-Aging Rejuvenating Face Cream - 2 oz
It is now possible to diminish visible signs of facial-skin photoaging by harnessing the power of coffee compounds. Many of its dramatic effects are linked to its caffeine content and the ability of caffeine to inhibit an enzyme called phosphodiesterase, which can produce a localized diuretic effect. This leads to reduced puffiness under the eyes.
Facial skin retains its youthful, vibrant glow thanks to a resilient framework of connective tissue formed by the proteins collagen and elastin, and water-binding glycosaminoglycans.1 These molecules make up the skin’s extracellular matrix that supports the suppleness of the skin.1,2
However, free radicals generated by the pervasive ultraviolet rays of the sun are associated with a normal decline in this extracellular matrix.2,3 Over time, tell-tale signs of photoaging may appear—wrinkles, redness, roughness, and under-eye puffiness—especially in the sun-vulnerable regions such as the face.4,5
Concentrated coffee extracts can target multiple factors involved in facial skin aging. Scientists have shown that topical application of the highly active coffee compounds supports the natural capacity of the extracellular matrix to replenish connective tissue and restore water-binding molecules.6-8 Topically applied caffeine, for instance, helps support the body’s normal removal of ultraviolet light-damaged keratinocyte cells—the process a healthy body employs to inhibit skin photoaging.8 This promotes the appearance of firmer, more youthful-looking facial skin.9
Studies have demonstrated the effectiveness of coffee compounds—Coffea arabica seed oil as well as Coffea robusta seed extract, which is known to contain both chlorogenic acid and caffeine—on aging facial skin.
When applied directly to facial skin...
These coffee extracts have been combined into the new Cosmesis Anti-Aging Rejuvenating Face Cream to help provide support against the visible signs of photoaging. Suggested use is to apply this rejuvenating face cream to clean skin twice a day, morning and night.
- Australas J Dermatol. 1998 Feb;39(1):19-23.
- EMBO Rep. 2008 Nov; 9(11): 1073-7.
- EXS. 2006;(96):131-57.
- Coll Antropol. 2008 Oct;32 Suppl 2:177-80.
- Arch Dermatol. 2002 Nov;138(11):1462-70.
- J Cosmet Dermatol. 2009 Mar;8(1):56-62.
- Chem Pharm Bull (Tokyo). 2011;59(6):793-6.
- Br J Dermatol. 2007 May;156(5): 957-64.
- J Drugs Dermatol. 2010 Dec;9(12):1480-7.
- J Cosmet Dermatol. 2009 Sep;8(3):228-33.
|These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.|